BridgeMD
New treatment option for Partial Edentulism
Official title In Vivo Evaluation of the Accuracy of Immediate Screw-Retained Provisional Crowns Fabricated Using Digital Planning and Guided Surgery
ClinicalTrials.gov ID: NCT07315607
What this study is testing
- What it's testing
- This clinical trial aims to evaluate the in vivo accuracy of a fully digital workflow for the immediate placement of a previously fabricated screw-retained provisional crown using digital planning and guided implant surgery. The study will be conducted in partially edentulous adult patients requiring the replacement of a single tooth with an immediately loaded dental implant.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- Adults aged 18 years or older.
- Partially edentulous patients requiring replacement of a single tooth with an immediately loaded dental implant.
- Patients classified as ASA I or ASA II according to the American Society of Anesthesiologists physical status classification.
- Patients with clinical conditions allowing immediate implant placement with a minimum primary stability of ≥25 Ncm.
- Ability to understand the study procedures and provide written informed consent.
You likely can't join if
- Patients classified as ASA III or ASA IV, or with uncontrolled systemic conditions that may interfere with study participation.
- Presence of psychiatric or cognitive disorders that may compromise informed consent or protocol compliance.
- Inability to comply with the visit schedule or required evaluations.
- Any other condition that, in the investigator's judgment, could compromise patient safety, protocol adherence, or data validity.
See the full eligibility criteria
- Adults aged 18 years or older.
- Partially edentulous patients requiring replacement of a single tooth with an immediately loaded dental implant.
- Patients classified as ASA I or ASA II according to the American Society of Anesthesiologists physical status classification.
- Patients with clinical conditions allowing immediate implant placement with a minimum primary stability of ≥25 Ncm.
- Ability to understand the study procedures and provide written informed consent.
- Willingness to comply with the study protocol and attend required clinical visits.
- Patients classified as ASA III or ASA IV, or with uncontrolled systemic conditions that may interfere with study participation.
- Presence of psychiatric or cognitive disorders that may compromise informed consent or protocol compliance.
- Inability to comply with the visit schedule or required evaluations.
- Any other condition that, in the investigator's judgment, could compromise patient safety, protocol adherence, or data validity.
The study team makes the final eligibility decision.
Where it's taking place
- Madrid, Madrid, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Madrid, Madrid, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.